APUS 8-K 2026-07-13

Apimeds Pharmaceuticals US, Inc. (APUS) 8-K dated 2026-07-13 — accession 0001213900-26-077591. This URL is the filing, not the APUS hub.

Apimeds Pharmaceuticals US, Inc. (APUS) is a drug manufacturers - specialty & generic company listed on US.

Apimeds Pharmaceuticals US, Inc. filed a 8-K on 2026-07-13. Accession 0001213900-26-077591.

Cached items: 8.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Income-statement cache for APUS is thin on this filing URL. We will not invent exhibit numbers.

Not investment advice. The APUS SEC hub lists recent forms. The stock page is the research view.